Tactile Medical Introduces New ComfortEase™ Flexitouch® Plus Garments and Kylee™ Mobile Application
July 25 2022 - 7:30AM
Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq:
TCMD), a medical technology company focused on developing medical
devices for the treatment of patients with underserved chronic
diseases at home, announced today the full market release of its
new ComfortEase™ garments, part of the Flexitouch® Plus system. In
addition, Tactile Medical is putting the power of lymphedema health
tracking in the palm of patients’ hands with the launch of its
Kylee™ mobile application.
Enhancing the Patient Experience with
ComfortEase
Leveraging over 18,000 points of feedback from
patients and therapists, Tactile Medical redesigned the Flexitouch
Plus garments to be easier to use, better fitting and more
comfortable, all intended to improve patient experience and
satisfaction. Together with the Flexitouch Plus controller, the
ComfortEase garments provide patients with an effective system for
at-home therapy and symptom relief of lymphedema, a condition which
requires diligent daily management.
Empowering Patients Through Digital
Health Monitoring
Patients using the Flexitouch Plus system, as
well as those who are undiagnosed and concerned about their
swelling, now have access to the Kylee mobile application. This
application expands Tactile Medical’s ability to serve patients on
their journey to diagnosis. Kylee, a personal lymphedema assistant,
is available on both the iOS and Android platforms, and is intended
to help educate, manage symptoms and support patients to help them
get the most out of their therapies. The app enables users to
record their symptoms and treatments, and upload photos to track
changes over time. Kylee app users may also show their progress to
their doctor, which can lead to more informed conversations. The
free app includes Flexitouch Plus and Entre shipment and order
tracking, product tutorial videos and an education library which
provides helpful information about lymphedema and symptom
management.
“At Tactile Medical, we are driven to treat
patients with underserved chronic conditions and help them care for
themselves at home. The release of the ComfortEase garments and the
Kylee app marks an important step in furthering our Mission,” said
Kristie Burns, Senior Vice President of Marketing & Clinical
Affairs.
Learn more about the ComfortEase garments here
and Kylee app here.
About Tactile Medical
Tactile Medical is a leader in developing and
marketing at-home therapies for people suffering from underserved,
chronic conditions including lymphedema, lipedema, chronic venous
insufficiency and chronic pulmonary disease by helping them live
better and care for themselves at home. The company collaborates
with clinicians to expand clinical evidence, raise awareness,
increase access to care, reduce overall healthcare costs and
improve the quality of life for tens of thousands of patients each
year.
Legal Notice Regarding Forward-Looking
Statements
This release contains forward-looking
statements. Forward-looking statements are generally identifiable
by the use of words like “may,” “will,” “should,” “could,”
“expect,” “anticipate,” “estimate,” “believe,” “intend,”
“continue,” “confident,” “outlook,” “guidance,” “project,” “goals,”
“look forward,” “poised,” “designed,” “plan,” “return,” “focused,”
“prospects” or “remain” or the negative of these words or other
variations on these words or comparable terminology. The reader is
cautioned not to put undue reliance on these forward-looking
statements, as these statements are subject to numerous factors and
uncertainties outside of the Company’s control that can make such
statements untrue, including, but not limited to, the impacts of
the COVID-19 pandemic on the Company’s business, financial
condition and results of operations and the Company’s inability
mitigate such impacts; the adequacy of the Company’s liquidity to
pursue its business objectives; the Company’s ability to obtain
reimbursement from third party payers for its products; loss or
retirement of key executives, including prior to identifying a
successor; adverse economic conditions or intense competition; loss
of a key supplier; entry of new competitors and products; adverse
federal, state and local government regulation; technological
obsolescence of the Company’s products; technical problems with the
Company’s research and products; the Company’s ability to expand
its business through strategic acquisitions; the Company’s ability
to integrate acquisitions and related businesses; price increases
for supplies and components; the effects of current and future U.S.
and foreign trade policy and tariff actions; or the inability to
carry out research, development and commercialization plans. In
addition, other factors that could cause actual results to differ
materially are discussed in the Company’s filings with the SEC.
Investors and security holders are urged to read these documents
free of charge on the SEC’s website at http://www.sec.gov. The
Company undertakes no obligation to publicly update or revise its
forward-looking statements as a result of new information, future
events or otherwise.
Investor Inquiries:
Mike Piccinino, CFA
ICR Westwicke
investorrelations@tactilemedical.com
Tactile Systems Technology (NASDAQ:TCMD)
Historical Stock Chart
From Mar 2024 to Apr 2024
Tactile Systems Technology (NASDAQ:TCMD)
Historical Stock Chart
From Apr 2023 to Apr 2024